Hive vs Injective — how do they compare? Hive trades at Rp691.24 (market cap Rp394,74M, Rp9,26M 24h volume), while Injective trades at Rp78,615 (market cap Rp7,84T, Rp689,53M 24h volume). The key difference: Injective is far larger — about 19861.2× Hive's market cap, and Hive's circulating supply is 574,8M HIVE versus 100M INJ for Injective. Which is the better fit depends on your goals — on Pluang, investors hold Hive for 42 Days and Injective for 37 Days on average.
| HIVE | INJ | |
|---|---|---|
Market Cap | Rp394,74M | Rp7,84T |
Volume (24h) | Rp9,26M | Rp689,53M |
Circulating Supply | 574,8M HIVE | 100M INJ |
Typical Hold Time | 42 Days | 37 Days |
Signals from Pluang's Aura AI — not financial advice
HIVE is currently trading at Rp706.45 with a bearish technical outlook, showing mixed signals between oversold RSI readings and strong selling pressure on moving averages. The token faces immediate support at Rp693 and resistance at Rp716, with recent price action indicating consolidation near lower levels. Recent ecosystem developments include ongoing protocol optimizations and community governance discussions, though no major network upgrades have been announced recently.
Overall outlook remains cautious with potential for short-term rebounds given oversold conditions, but structural bearish momentum persists. Key opportunities include potential technical bounces from support levels, while major risks involve continued selling pressure and broader crypto market volatility. Investors should monitor network activity metrics and trading volume patterns for directional cues.
INJ is currently trading at Rp81,847 with a market cap of Rp8.18 trillion, showing bearish technical signals with moving averages indicating selling pressure while oscillators remain neutral. The token faces immediate resistance at Rp82,576 with support at Rp81,456. Recent on-chain data shows an average hold time of 37 days, suggesting moderate holding patterns among investors.
Overall outlook remains cautious with technical indicators favoring bearish momentum. Key opportunities include potential bounce from support levels, while major risks involve continued selling pressure and crypto market volatility. Investors should monitor network adoption metrics and exchange liquidity closely.
What Pluang investors did over the last 30 days
Latest headlines on both assets
HIVE is a decentralized information sharing network with an accompanying blockchain-based financial ledger built on the Delegated Proof of Stake (DPoS) protocol. Hive is developed to store vast amounts of content and to make it available for time-based monetization. Examples of use include social media with monetized rewards for content producers, interactive games, identity management, polling systems, and micro-loans.
Read more on HIVE →Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →